RA Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

RA Capital Management’s Portfolio PHAS Stock Details PHAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,850,000	Closed	-$3.76M	–	109
2022 Q1	$3.76M	Hold	2,850,000	–	–	0.08%	90
2021 Q4	$7.44M	Hold	2,850,000	–	–	0.13%	87
2021 Q3	$8.86M	Hold	2,850,000	–	–	0.12%	81
2021 Q2	$10.6M	Hold	2,850,000	–	–	0.17%	72
2021 Q1	$9.86M	Buy	+2,850,000	New	+$11.6M	0.15%	72

Other funds holding PHAS

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAI Capital Management Independence, Ohio $17.6B AUM 18.87% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Stifel Financial

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return